Literature DB >> 18077600

Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule.

Adriana Castello Costa Girardi1, Lívia Emy Fukuda, Luciana Venturini Rossoni, Gerhard Malnic, Nancy Amaral Rebouças.   

Abstract

In the microvillar microdomain of the kidney brush border, sodium hydrogen exchanger type 3 (NHE3) exists in physical complexes with the serine protease dipeptidyl peptidase IV (DPPIV). The purpose of this study was to explore the functional relationship between NHE3 and DPPIV in the intact proximal tubule in vivo. To this end, male Wistar rats were treated with an injection of the reversible DPPIV inhibitor Lys [Z(NO2)]-pyrrolidide (I40; 60 mg.kg(-1).day(-1) ip) for 7 days. Rats injected with equal amounts of the noninhibitory compound Lys[Z(NO2)]-OH served as controls. Na(+) - H(+) exchange activity in isolated microvillar membrane vesicles was 45 +/- 5% decreased in rats treated with I40. Membrane fractionation studies using isopycnic centrifugation revealed that I40 provoked redistribution of NHE3 along with a small fraction of DPPIV from the apical enriched microvillar membranes to the intermicrovillar microdomain of the brush border. I40 significantly increased urine output (67 +/- 9%; P < 0.01), fractional sodium excretion (63 +/- 7%; P < 0.01), as well as lithium clearance (81 +/- 9%; P < 0.01), an index of end-proximal tubule delivery. Although not significant, a tendency toward decreased blood pressure and plasma pH/HCO(3)(-) was noted in I40-treated rats. These findings indicate that inhibition of DPPIV catalytic activity is associated with inhibition of NHE3-mediated NaHCO3 reabsorption in rat renal proximal tubule. Inhibition of apical Na(+) - H(+) exchange is due to reduced abundance of NHE3 protein in the microvillar microdomain of the kidney brush border. Moreover, this study demonstrates a physiologically significant interaction between NHE3 and DPPIV in the intact proximal tubule in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077600     DOI: 10.1152/ajprenal.00174.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  46 in total

1.  Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis.

Authors:  Luciana C Veiras; Adriana C C Girardi; Joshua Curry; Lei Pei; Donna L Ralph; An Tran; Regiane C Castelo-Branco; Nuria Pastor-Soler; Cristina T Arranz; Alan S L Yu; Alicia A McDonough
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

Review 2.  Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes.

Authors:  Amy Christine Engevik; James R Goldenring
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

Review 3.  NHE3 regulatory complexes.

Authors:  Mark Donowitz; Sachin Mohan; Cindy Xinjun Zhu; Tian-E Chen; Rong Lin; Boyoung Cha; Nicholas C Zachos; Rakhilya Murtazina; Rafiquel Sarker; Xuhang Li
Journal:  J Exp Biol       Date:  2009-06       Impact factor: 3.312

4.  Functional role of glucose metabolism, osmotic stress, and sodium-glucose cotransporter isoform-mediated transport on Na+/H+ exchanger isoform 3 activity in the renal proximal tubule.

Authors:  Thaissa Dantas Pessoa; Luciene Cristina Gastalho Campos; Luciene Carraro-Lacroix; Adriana C C Girardi; Gerhard Malnic
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

5.  The calcineurin homologous protein-1 increases Na(+)/H(+) -exchanger 3 trafficking via ezrin phosphorylation.

Authors:  Francesca Di Sole; Victor Babich; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2009-06-25       Impact factor: 10.121

Review 6.  Molecular mechanisms and regulation of urinary acidification.

Authors:  Ira Kurtz
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.

Authors:  Koichi Kanozawa; Yuichi Noguchi; Souichi Sugahara; Satoko Nakamura; Hirohisa Yamamoto; Keiko Kaneko; Rika Kono; Saeko Sato; Tomonari Ogawa; Hajime Hasegawa; Shigehiro Katayama
Journal:  Clin Exp Nephrol       Date:  2017-12-23       Impact factor: 2.801

Review 8.  DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

Authors:  Jixin Zhong; Andrei Maiseyeu; Stephen N Davis; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 9.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 10.  Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4.

Authors:  Volker Vallon; Neil G Docherty
Journal:  Exp Physiol       Date:  2014-08-01       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.